It is a prokinetic benzamide derivative unlike metoclopramide or domperidone
Itopride
Itopride; 122898-67-3; N-(4-(2-(Dimethylamino)ethoxy)benzyl)-3,4-dimethoxybenzamide; UNII-81BMQ80QRL; Itopride
Abepra-ISR, Acera-IT, Alizole-IP, Ampty, Anto-ISR, Antuc-IT, Asterab-IT, Avtop-I, Beerab-ISR, Bizo-IT, Brazo-IT, Cool Rab-IT, Cyra-IT, Domol-ISR, Furab-IT, Ganaton, Ganaton Total, Ganaton-OD, Gasorab-TXR, Gepride-50, GI-Tune, GI-Tune MPS, GI-Tune-SR, Gimate, Gitrak, Gitune, Gitune-SR, Itcan, Itokine, Itonix, Itonorm, Itopie-RD, Itoplus, Itopraz, Itoprid, Itorab, Itorbe-SR, Itotor-OD, Itoz, Itza, Jeprab-ITO, Kool-IT, Kurepan-IT, Mac-IT, Motiza, Motiza-Mps, Novorab Plus, Nupenta-ITR, Nura-IT, Olprid
N-({4-[2-(dimethylamino)ethoxy]phenyl}methyl)-3,4-dimethoxybenzamide
NA
NA
The recommended dose is 50 mg 3 times/day.
Itopride is indicated for the treatment of functional dyspepsia and other gastrointestinal conditions.
Rash, diarrhoea, constipation, abdominal pain, headache, sleeping disorders, dizziness, galactorrhea, gynecomastia.
Anticholinergic agents reduce the action of itopride
Hypersensitivity; lactation. GI haemorrhage, obstruction or perforation.
Store it at room temperature (25°C).
358.4314
C20H26N2O4
122898-67-3
Pregnancy, elderly
